用于诊断非酒精性脂肪性肝炎的生化评分系统。
Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis.
作者信息
Noor-E-Alam Mohammad, Alam Shahinul, Alam Akm Khorshed, Mahtab Mamun Al, Rahman Salimur
机构信息
Department of Hepatology, Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh.
Department of Hepatology Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
出版信息
Euroasian J Hepatogastroenterol. 2016 Jul-Dec;6(2):202-204. doi: 10.5005/jp-journals-10018-1201. Epub 2016 Dec 1.
Abstract
Noor-E-Alam M, Alam S, Alam AKMK, Al Mahtab M, Rahman S. Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis. Euroasian J Hepato-Gastroenterol 2016;6(2):202-204.
摘要
努尔-伊-阿拉姆·M、阿拉姆·S、阿拉姆·AKMK、阿尔·马赫塔布·M、拉赫曼·S。用于诊断非酒精性脂肪性肝炎的生化评分系统。《欧亚肝脏胃肠病学杂志》2016年；6(2):202 - 204。
相似文献
1
Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis.用于诊断非酒精性脂肪性肝炎的生化评分系统。
Euroasian J Hepatogastroenterol. 2016 Jul-Dec;6(2):202-204. doi: 10.5005/jp-journals-10018-1201. Epub 2016 Dec 1.
2
A Case Report of Decompensated Cirrhosis of Liver with Sideroblastic Anemia.
Euroasian J Hepatogastroenterol. 2015 Jan-Jun;5(1):55-56. doi: 10.5005/jp-journals-10018-1132. Epub 2015 Jan 6.
3
Distribution of Liver Disease in Bangladesh: A Cross-country Study.孟加拉国肝脏疾病的分布：一项跨国研究。
Euroasian J Hepatogastroenterol. 2014 Jan-Jun;4(1):25-30. doi: 10.5005/jp-journals-10018-1092. Epub 2014 Jan 22.
4
Therapeutic Endoscopy during COVID-19 Pandemic: An Observational Study from Bangladesh.新冠疫情期间的治疗性内镜检查：来自孟加拉国的一项观察性研究
Euroasian J Hepatogastroenterol. 2020 Jan-Jun;10(1):47-49. doi: 10.5005/jp-journals-10018-1318.
5
Abdominal Tuberculosis: A Diagnostic Dilemma.腹部结核：诊断难题
Euroasian J Hepatogastroenterol. 2015 Jan-Jun;5(1):57-59. doi: 10.5005/jp-journals-10018-1133. Epub 2015 Jan 6.
6
New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease.结合FIB-4指数和细胞角蛋白-18片段的新型评分系统用于预测非酒精性脂肪性肝病患者的脂肪性肝炎和肝纤维化
Biomarkers. 2018 May-Jun;23(4):328-334. doi: 10.1080/1354750X.2018.1425915. Epub 2018 Jan 19.
7
Management of Hepatocellular Carcinoma: Bangladesh Perspective.肝细胞癌的管理：孟加拉国视角
Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):52-53. doi: 10.5005/jp-journals-10018-1258. Epub 2018 May 1.
8
Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.肝星状细胞激活发生在非酒精性脂肪性肝炎中。
Hepatogastroenterology. 2001 Jan-Feb;48(37):87-90.
9
An Outbreak of Acute Hepatitis in a Medical Facility of Bangladesh.孟加拉国一家医疗机构爆发急性肝炎疫情。
Euroasian J Hepatogastroenterol. 2014 Jan-Jun;4(1):66-67. doi: 10.5005/jp-journals-10018-1102. Epub 2014 Jan 22.
10
Role of Biobran (Arabinoxylan Rice Bran) on Patients with Advanced Stage Hepatocellular Carcinoma.生物麸皮（阿拉伯木聚糖米糠）在晚期肝细胞癌患者中的作用。
Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):84-88. doi: 10.5005/jp-journals-10018-1407.
本文引用的文献
1
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎纤维化进展危险因素的系统评价
J Hepatol. 2009 Aug;51(2):371-9. doi: 10.1016/j.jhep.2009.03.019. Epub 2009 May 3.
2
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.非酒精性脂肪性肝病纤维化评分：一种用于识别非酒精性脂肪性肝病患者肝纤维化的非侵入性系统。
Hepatology. 2007 Apr;45(4):846-54. doi: 10.1002/hep.21496.
3
Diagnostic evaluation of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的诊断评估
J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S34-8. doi: 10.1097/01.mcg.0000168642.38945.f1.
4
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝纤维化的独立预测因素
Hepatology. 1999 Dec;30(6):1356-62. doi: 10.1002/hep.510300604.
Zotero 插件